Jie Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Top Venues

Therapeutic advances in medical oncology

The clinical respiratory journal

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Liuxian Guo, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, Jie Chen
The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis. The clinical respiratory journal 18 (4) (2024)
Guojin Zhou, Liuxian Guo, Jing Xu, Kejing Tang, Jie Chen
Comparison of osimertinib plus bevacizumab against osimertinib alone in NSCLC harboring EGFR mutations: a systematic review and meta-analysis. Therapeutic advances in medical oncology 16 (2024)
Guojin Zhou, Liuxian Guo, Jing Xu, Kejing Tang, Jie Chen
Comparison of osimertinib plus bevacizumab against osimertinib alone in NSCLC harboring EGFR mutations: a systematic review and meta-analysis. Therapeutic advances in medical oncology 16 (2024)
Liuxian Guo, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, Jie Chen
The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis. The clinical respiratory journal 18 (4) (2024)
Yubo Tang, Qingde Wa, Long-Yun Peng, Yifan Zheng, Jie Chen, Xiao Chen, Xuenong Zou, Huangxuan Shen, Shuai Huang
Salvianolic Acid B Suppresses ER Stress-Induced NLRP3 Inflammasome and Pyroptosis via the AMPK/FoxO4 and Syndecan-4/Rac1 Signaling Pathways in Human Endothelial Progenitor Cells. Oxidative medicine and cellular longevity 2022 (2022)